Effect of Almond Supplementation on the Anthropometric Measurements, Biochemical Parameters and Blood Pressure Levels of Men with Metabolic Syndrome

Jump To References Section


  • Department of Home Science, Women's Christian College, Chennai ,IN
  • Center for Nutrition Counseling and Extension Activities, Chennai ,IN


Metabolic Syndrome, Almonds, Cardiovascular Risk, Chronic Diseases.


The prevalence of metabolic syndrome is increasing to epidemic proportions in developing nations. Therapeutic lifestyle changes are the first line of treatment for metabolic syndrome. Functional foods like almonds may be helpful adjuncts to a dietary approach and improve the risk factors for metabolic syndrome. The purpose of this study was to evaluate the effects of almond supplementation on the anthropometric measurements, biochemical parameters and blood pressure levels of men with metabolic syndrome. The study was a pre-test, post-test experimental design with a test group on supplementation and a control group without supplementation. Three hundred and eighty men in the age group of 25 to 50 years were screened for metabolic syndrome using the National Cholesterol Education Program Adult Treatment Panel III Criteria. A total of eighty male subjects with metabolic syndrome were selected, fifty were assigned to the test group and the remaining thirty subjects were assigned to the control group and were not given any supplementation. The results showed that a statistically significant (p<0.001) reduction in all the anthropometric parameters and there was a significant decrease in the total cholesterol (p<0.05), LDL-C (p<0.05) and TC:HDL-C (p<0.05) and LDL:HDL-Cratios (p<0.01) at the end of the six week almond supplementation period. There was a significant (p<0.01) reduction in the systolic blood pressure level and a non-significant reduction in the diastolic blood pressure level. Almond supplementation showed a favorable effect and they promote cardiovascular health by providing monounsaturated fats, high potassium and low sodium, making almonds an especially good choice in treating metabolic syndrome.


Download data is not yet available.



How to Cite

Annette Beatrice, D., & Shivaji, G. (2015). Effect of Almond Supplementation on the Anthropometric Measurements, Biochemical Parameters and Blood Pressure Levels of Men with Metabolic Syndrome. The Indian Journal of Nutrition and Dietetics, 52(2), 184–191. Retrieved from https://www.informaticsjournals.com/index.php/ijnd/article/view/2460



WHO, World Health Report-2002. Reducing Risks, Promoting Healthy Life, Geneva, Switzerland. World Health Organization, 2002.

Cornier, M.A., Diabelea, D., Hernandez, T.L., Linderstorm, R.C., Steig, A.J., Stob, N.R., Van Pelt, R.E. Wang, H. and Eckel, R.H., The metabolic syndrome. Endocr. Rev., 2008, 29(7), 777-822.

Griel, A.E. and Kris-Etherton, P.M., Tree nuts and the lipid Profile. A review of clinical studies. Brit. J. Nutr., 2006, 96(Suppl 2): S68-S78.

Spiller, G.A., Miller, A., Olivera, K., Reynolds, J., Miller, B., Morse, S.J., Dewell, A. and Farguhar, J.W., Effects of plant-baseddiets high in raw or roasted almonds, or roasted almond butteron serum lipoproteins in humans. J. Am. Coll. Nutr., 2003, 22, 195-200.

Jenkins, D.J., Kendall, C.W., Marchie, A., Parker, T.L., Connelly, P.W., Qian, W., Haight, J.S., Faulkner, D., Vidgen, E., Lapsley, K.G. and Spiller, G.A., Dose response of almonds on coronary heart disease risk factors, blood lipids, oxidized low-density lipoproteins, lipoprotein(a), homocysteine and pulmonary nitric oxide. A randomized, ontrolled, crossover trial. Circulation. 2002b, 106, 1327.

Sabate, J., Haddad, E., Tanzman, J.S., Jambazian, P. and Rajaram, S., Serum lipid response to the graduated enrichment of a Step I diet with almonds: a randomized feeding trial. Am. J. Clin. Nutr., 2003, 77, 1379-1384.

Wien, M.A., Sabate, J.M., Ikle, D.N., Cole, S.E. and Kandeel, F.R., Almonds vs complex carbohydrates in a weight reduction program. Int J. Obes. Relat. Metab. Disord. 2003, 27, 1365-1372.

Abbey, M., Noakes, M., Belling, G.B. and Nestel, P. J., Partial replacement of saturated fatty acids with almonds or walnuts lowers total plasma cholesterol and low-density-lipoprotein cholesterol. Am. J. Clin. Nutr., 1994, 59, 995-999.

Lovejoy, J.C., Most, M.M., Lefevre, M., Greenway, F.L. and Rood, J.C., Effect of diets enriched in almonds on insulin action and serum lipids in adults with normal glucose tolerance or type 2 diabetes. Am. J. Clin. Nutr., 2002, 76, 1000-1006.

Jenkins, D.J., Kendall, C.W.C., Josse, J.R., Salvatore, S., Brighenti, F., Augustin, L.S.A., Ellis, P.R., Vidgen.E. and Rao, A.V., Almonds Decrease Postprandial Glycemia, Insulinemia, and Oxidative Damage in Healthy Individuals. 2006.

Hollis, J. and Mattes, R., Effect of chronic consumption of almonds on body weight in healthy humans. Brit. J. Nutr., 2007, 98, 651-656. J. Nutr.136, 2987-2992.

Berry, E.A., Tydeman, H.B., Lewis, Phalora, R., Rosborough, J., Picout, D.R. and Ellis, P.R., Manipulation of lipid bioaccessibility of almond seeds influences postprandial lipemia in healthy human subjects. Am. J. Clin. Nutr., 2008, 88, 922-929.